The role of AI in clinical trials

Finding the right patients for the right clinical trials has always been one of the biggest challenges in research. Recruitment delays, eligibility mismatches and dropouts cost time and money. Most importantly, they delay access to potentially life-changing treatments.

Artificial intelligence is now changing how clinical trials are designed and delivered. From recruitment to retention, AI in clinical trials is helping researchers and sponsors improve efficiency, increase accuracy and create a more seamless experience for patients. Large technology companies like Google Health and OpenAI are exploring AI’s role in healthcare, while clinical-focused platforms like IBM Watson Health and Tempus are working on AI-driven clinical insights, diagnostics and patient matching.

In this article, we explore how AI is being used in clinical trials, how it helps with patient matching and recruitment, and how it supports faster, smarter research.

Using AI in clinical trials

AI refers to the use of software that can analyse patterns, learn from data and support decision-making. In clinical trials, it is being used to automate manual processes, identify eligible patients, and reduce delays in recruitment and follow-up.

Using AI in clinical trials allows teams to manage large volumes of information faster and with fewer errors. For example, AI tools can screen medical records, cross-check eligibility criteria and automatically send reminders to participants. This helps trial teams focus on what matters most—delivering safe and effective studies.

How is AI matching clinical trial patients?

One of the most powerful applications of AI is in clinical trial matching. This involves scanning patient data, such as medical history and current health status, to find suitable trial opportunities.

So, how is AI matching clinical trial patients more effectively than traditional methods? AI systems can process structured and unstructured data, including doctors’ notes, test results and digital health records. By identifying patterns that humans might miss, these systems can find more accurate matches faster.

If you’ve ever wondered, can AI help me find a clinical trial? The answer is yes. Clinrol’s platform uses AI to match patients with studies that suit their condition, location and preferences. It makes the process quicker and easier for both patients and research teams.

The benefits of AI clinical trial matching

Traditional recruitment relies on advertising, referrals or patient databases. These methods can be slow and may not always identify the best candidates.

AI clinical trial matching changes the game. It allows for faster identification of eligible patients, improves precision, and reduces the risk of enrolling people who later turn out not to meet the criteria.

It also benefits patients by helping them discover studies that may otherwise never have reached them. For sponsors, working with patient recruitment sponsors who use AI tools means more efficient enrolment, fewer dropouts and better trial outcomes.

To see which trials may be relevant to you, find a clinical trial through Clinrol’s AI-powered platform.

AI clinical trial recruitment in action

AI clinical trial recruitment combines automation with patient engagement. For example, once a potential participant has been identified, AI tools can send personalised messages, book appointments or even conduct AI pre-screening calls.

This helps reduce pressure on site staff and ensures participants stay informed and supported throughout the process.

At Clinrol, we combine AI with human oversight to make sure participants feel guided, not overwhelmed. Our approach improves the experience for clinical trial patients and boosts results for researchers.

How can AI improve the efficiency of clinical trials?

If you’re wondering how AI can improve the efficiency of clinical trials, here are a few examples:

• Quicker identification of eligible patients
  Lower screen failure rates

• Automated scheduling and communication

• Better data consistency and oversight

• More targeted outreach to underrepresented groups
  

These improvements help trials start sooner, finish faster and generate stronger data. In an environment where time and trust are essential, AI helps lift both.

What’s next for AI in clinical trials?

The use of AI in clinical trials is still evolving. As technology becomes more advanced, researchers will be able to predict challenges, personalise trial pathways and engage participants more effectively.

At the same time, regulatory bodies like the Therapeutic Goods Administration (TGA) in Australia and the Food and Drug Administration (FDA) in the United States are providing new guidance on how AI can be used safely and ethically in research.

While AI will never replace human judgment, it is proving to be a valuable tool for improving how trials are delivered and how quickly patients can access promising treatments.

For more on how AI can improve the efficiency of clinical trials, the National Institutes of Health has shared several use cases of AI supporting faster enrolment and real-time data insights. You can also read more about using AI in clinical trials and healthcare innovation through the Department of Health’s official AI in health paper.

The role of AI voice in patient engagement

As AI in clinical trials continues to mature, one of the biggest opportunities lies in how patients are engaged after initial interest. Matching is only the first step. Ongoing communication, follow-up and support are what keep trials moving.

Clinrol Connect is designed to support this next phase. It combines intelligent matching with AI-powered voice technology to help research teams engage participants more quickly and consistently. AI voice assistants can handle tasks such as eligibility checks, appointment reminders and follow-up calls, reducing delays while still keeping the experience clear and human.

For patients, this means quicker responses and fewer missed steps. For sites and sponsors, it helps scale recruitment and engagement without adding pressure to already stretched teams. Used responsibly, AI voice supports better continuity and helps ensure no potential participant falls through the cracks.

This approach shows how AI in clinical trials is moving beyond data analysis alone to real-world, patient-facing interactions that improve both efficiency and experience.

Final thoughts

AI in clinical trials is no longer a future idea. It’s already making a real impact, helping patients get matched to the right studies and helping researchers reach their goals more efficiently.

Whether you are a sponsor, a trial site or a patient, AI tools can simplify the process and improve the outcome.

To see how AI could help you take part in a study, find a clinical trial or learn more through the Clinrol’s platform, Clinrol Connect.